A 16 week trial of VTP-43742 in psoriatic patients

Trial Profile

A 16 week trial of VTP-43742 in psoriatic patients

Planning
Phase of Trial: Phase II

Latest Information Update: 03 Aug 2016

At a glance

  • Drugs VTP 43742 (Primary)
  • Indications Psoriasis
  • Focus Therapeutic Use
  • Sponsors Vitae Pharmaceuticals
  • Most Recent Events

    • 03 Aug 2016 According to a Vitae Pharmaceuticals media release, this trial is expected to initiate in the fourth quarter of 2016 and expects to report top-line data in the second half of 2017.
    • 17 Mar 2016 New trial record
    • 16 Mar 2016 According to a Vitae Pharmaceuticals media release, this trial is expected to initiate in the second half of 2016.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top